A Randomised, Open-label, Parallel-group Study to Evaluate the Efficacy and Safety of ACTIQ (Oral Transmucosal Fentanyl Citrate) Titrated According to 2 Regimens in Patients With Cancer and Breakthrough Pain
Latest Information Update: 04 Feb 2013
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Registrational; Therapeutic Use
- Sponsors Cephalon
- 04 Feb 2013 New trial record